Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects
Aimee K. Bence, Eric B. Anderson, Maqbool A. Halepota, Michael A. Doukas, Phillip A. DeSimone, George A. Davis, Deborah A. Smith, Kevin M. Koch, Andrew G. Stead, Steve Mangum, Carolyn J. Bowen, Neil LVolume:
23
Language:
english
Pages:
11
DOI:
10.1023/b:drug.0000047104.45929.ea
Date:
January, 2005
File:
PDF, 170 KB
english, 2005